Department of Justice – Federal Register Recent Federal Regulation Documents

Results 1 - 50 of 12,704
Bulk Manufacturer of Controlled Substances Application: Janssen Pharmaceuticals Inc.
Document Number: 2020-26651
Type: Notice
Date: 2020-12-03
Agency: Drug Enforcement Administration, Department of Justice
Janssen Pharmaceuticals Inc., has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplemental Information listed below for further drug information.
Agency Information Collection Activities; Proposed eCollection eComments Requested; Revision of a Currently Approved Collection; Final Disposition Report (R-84), With Supplemental Questions R-84(a), R-84(b), R-84(c), R-84(d), R-84(e), R-84(f), R-84(g), R-84(h), R-84(i), and R-84(j)
Document Number: 2020-26634
Type: Notice
Date: 2020-12-03
Agency: Federal Bureau of Investigation, Department of Justice
The Criminal Justice Information Services (CJIS) Division, Federal Bureau of Investigation (FBI), Department of Justice (DOJ), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995.
Schedules of Controlled Substances: Temporary Placement of Brorphine in Schedule I
Document Number: 2020-26301
Type: Proposed Rule
Date: 2020-12-03
Agency: Drug Enforcement Administration, Department of Justice
The Acting Administrator of the Drug Enforcement Administration is issuing this notice of intent to publish a temporary order to schedule 1-(1-(1-(4-bromophenyl)ethyl)piperidin-4-yl)-1,3- dihydro-2H-benzo[d]imidazol-2-one (commonly known as brorphine), including its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers whenever the existence of such isomers, esters, ethers, and salts is possible, in schedule I of the Controlled Substances Act. When it is issued, the temporary scheduling order will impose the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis, or possess) or propose to handle brorphine.
Agency Information Collection Activities; Proposed eCollection eComments Requested; Extension With Change of a Currently Approved Collection Application and Permit for Temporary Importation of Firearms and Ammunition by Nonimmigrant Aliens-ATF Form 6NIA (5330.3D)
Document Number: 2020-26585
Type: Notice
Date: 2020-12-02
Agency: Department of Justice, Bureau of Alcohol, Tobacco, Firearms and Explosives
The Department of Justice (DOJ), Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF), will submit the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995.
Manner of Federal Executions
Document Number: C1-2020-25867
Type: Rule
Date: 2020-12-01
Agency: Department of Justice, Office of the Attorney General
Agency Information Collection Activities; Proposed eCollection eComments Requested; Notification of Change of Mailing or Premise Address
Document Number: 2020-26464
Type: Notice
Date: 2020-12-01
Agency: Department of Justice, Bureau of Alcohol, Tobacco, Firearms and Explosives
The Department of Justice (DOJ), Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF), will submit the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995.
Final Adjusted Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2020
Document Number: 2020-26443
Type: Notice
Date: 2020-12-01
Agency: Drug Enforcement Administration, Department of Justice
This final order establishes the final adjusted 2020 aggregate production quotas for controlled substances in schedules I and II of the Controlled Substances Act and the assessment of annual needs for the list I chemicals ephedrine, pseudoephedrine, and phenylpropanolamine.
Agency Information Collection Activities; Proposed eCollection eComments Requested; Extension of a Currently Approved Collection: Capital Punishment Report of Inmates Under Sentence of Death
Document Number: 2020-26377
Type: Notice
Date: 2020-12-01
Agency: Department of Justice
The Bureau of Justice Statistics, Office of Justice Programs, Department of Justice (DOJ), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995.
Notice Pursuant to the National Cooperative Research and Production Act of 1993-ODPI, Inc.
Document Number: 2020-26360
Type: Notice
Date: 2020-11-30
Agency: Antitrust Division, Department of Justice
Established Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2021
Document Number: 2020-26289
Type: Notice
Date: 2020-11-30
Agency: Drug Enforcement Administration, Department of Justice
This final order establishes the initial 2021 aggregate production quotas for controlled substances in schedules I and II of the Controlled Substances Act and the assessment of annual needs for the list I chemicals ephedrine, pseudoephedrine, and phenylpropanolamine.
Delegation of Defense Production Act Authority
Document Number: 2020-26222
Type: Rule
Date: 2020-11-27
Agency: Department of Justice
This final rule authorizes the Assistant Attorney General in charge of the Antitrust Division to perform, as the delegate of the Attorney General, all functions that the Attorney General is required or authorized to perform by section 708 of the Defense Production Act (``DPA'').
Importer of Controlled Substances Application: Lyndra Therapeutics
Document Number: 2020-26175
Type: Notice
Date: 2020-11-27
Agency: Drug Enforcement Administration, Department of Justice
Lyndra Therapeutics has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplemental Information listed below for further drug information.
Importer of Controlled Substances Application: Noramco Inc.
Document Number: 2020-26174
Type: Notice
Date: 2020-11-27
Agency: Drug Enforcement Administration, Department of Justice
Noramco Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplemental Information listed below for further drug information.
Importer of Controlled Substances Application: Meridian Medical Technologies
Document Number: 2020-26172
Type: Notice
Date: 2020-11-27
Agency: Drug Enforcement Administration, Department of Justice
Meridian Medical Technologies has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplemental Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Novitium Pharma LLC
Document Number: 2020-26171
Type: Notice
Date: 2020-11-27
Agency: Drug Enforcement Administration, Department of Justice
Novitium Pharma LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplemental Information listed below for further drug information.
Good Cause for a Continuance in Immigration Proceedings
Document Number: 2020-25931
Type: Proposed Rule
Date: 2020-11-27
Agency: Executive Office for Immigration Review, Department of Justice
The Department of Justice (``Department'' or ``DOJ'') is proposing to define ``good cause,'' in the context of continuances, adjournments, and postponements, in its immigration regulations.
Motions To Reopen and Reconsider; Effect of Departure; Stay of Removal
Document Number: 2020-25912
Type: Proposed Rule
Date: 2020-11-27
Agency: Executive Office for Immigration Review, Department of Justice
The Department of Justice (``Department'') proposes to amend Executive Office for Immigration Review (``EOIR'') regulations governing the filing and adjudication of motions to reopen and reconsider and to add regulations governing requests for discretionary stays of removal.
Manner of Federal Executions
Document Number: 2020-25867
Type: Rule
Date: 2020-11-27
Agency: Department of Justice, Office of the Attorney General
The Department of Justice (``Department'' or ``DOJ'') is finalizing amendments to regulations to authorize implementation of a sentence in a Federal capital case in any manner consistent with Federal law and to make other amendments.
FSA Time Credits
Document Number: 2020-25597
Type: Proposed Rule
Date: 2020-11-25
Agency: Department of Justice, Bureau of Prisons
This proposed rule would codify the Bureau of Prisons (Bureau) procedures regarding time credits as authorized by the First Step Act of 2018 (FSA), hereinafter referred to as ``FSA Time Credits.'' The FSA provides that eligible inmates may earn FSA Time Credits towards pre- release custody or early transfer to supervised release for successfully completing approved Evidence-Based Recidivism Reduction programs or Productive Activities that are assigned to the inmate based on the inmate's risk and needs assessment. Eligible inmates include those individuals who are sentenced under the U.S. Code and in the custody of the Bureau. However, as required by the FSA, an inmate cannot earn FSA Time Credits if he or she is serving a sentence for a disqualifying offense or has a disqualifying prior conviction. However, these inmates can still earn other benefits, as authorized by the Bureau, for successfully completing recidivism reduction programming.
Schedules of Controlled Substances: Placement of cyclopentyl fentanyl, isobutyryl fentanyl, para-chloroisobutyryl fentanyl, para-methoxybutyryl fentanyl, and valeryl fentanyl in Schedule I
Document Number: 2020-22757
Type: Rule
Date: 2020-11-25
Agency: Drug Enforcement Administration, Department of Justice
The Drug Enforcement Administration places cyclopentyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N- phenylcyclopentanecarboxamide), isobutyryl fentanyl (N-(1- phenethylpiperidin-4-yl)-N-phenylisobutyramide), para-chloroisobutyryl fentanyl (N-(4-chlorophenyl)-N-(1-phenethylpiperidin-4- yl)isobutyramide), para-methoxybutyryl fentanyl (N-(4-methoxyphenyl)-N- (1-phenethylpiperidin-4-yl)butyramide), and valeryl fentanyl (N-(1- phenethylpiperidin-4-yl)-N-phenylpentanamide), including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers whenever the existence of such isomers, esters, ethers, and salts is possible, in schedule I of the Controlled Substances Act. This action continues the imposition of the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, import, export, engage in research, conduct instructional activities or chemical analysis with, or possess), or propose to handle cyclopentyl fentanyl, isobutyryl fentanyl, para-chloroisobutyryl fentanyl, para- methoxybutyryl fentanyl, and valeryl fentanyl.
Agency Information Collection Activities; Proposed eCollection eComments Requested; Extension of a Currently Approved Collection
Document Number: 2020-25948
Type: Notice
Date: 2020-11-24
Agency: Department of Justice
The Department of Justice, Office on Violence Against Women (OVW) will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995.
Agency Information Collection Activities; Proposed eCollection eComments Requested; Extension of a Currently Approved Collection
Document Number: 2020-25947
Type: Notice
Date: 2020-11-24
Agency: Department of Justice
The Department of Justice, Office on Violence Against Women (OVW) will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995.
Agency Information Collection Activities; Proposed eCollection eComments Requested; Extension of a Currently Approved Collection
Document Number: 2020-25946
Type: Notice
Date: 2020-11-24
Agency: Department of Justice
The Department of Justice, Office on Violence Against Women (OVW) will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995.
Agency Information Collection Activities; Proposed eCollection eComments Requested; Extension of a Currently Approved Collection
Document Number: 2020-25945
Type: Notice
Date: 2020-11-24
Agency: Department of Justice
The Office on Violence Against Women (OVW), Department of Justice, will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995.
Agency Information Collection Activities; Proposed eCollection eComments Requested; Extension of a Currently Approved Collection
Document Number: 2020-25944
Type: Notice
Date: 2020-11-24
Agency: Department of Justice
The Department of Justice, Office on Violence Against Women (OVW) will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995.
Agency Information Collection Activities; Proposed eCollection eComments Requested; Revision of a Currently Approved Collection; Friction Ridge Cards: Arrest and Institution FD-249; Applicant FD-258; Identity History Summary Request FD-1164; FBI Standard Palm Print FD-884; Supplemental Finger and Palm Print FD-884a
Document Number: 2020-25943
Type: Notice
Date: 2020-11-24
Agency: Department of Justice
Department of Justice (DOJ), Federal Bureau of Investigation (FBI), Criminal Justice Information Services (CJIS) Division is submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995.
Bulk Manufacturer of Controlled Substances Application: Johnson Matthey Pharmaceutical Materials Inc.
Document Number: 2020-25764
Type: Notice
Date: 2020-11-23
Agency: Drug Enforcement Administration, Department of Justice
Johnson Matthey Pharmaceutical Materials Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplemental Information listed below for further drug information.
Agency Information Collection Activities; Proposed eCollection eComments Requested; Extension, Without Change, of a Currently Approved Collection; FBI eFOIA Form
Document Number: 2020-25462
Type: Notice
Date: 2020-11-20
Agency: Federal Bureau of Investigation, Department of Justice
The Federal Bureau of Investigation, Department of Justice (DOJ), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995.